v3.26.1
Note 16 - Dermadoctor Divestiture (Tables)
 12 Months Ended
Dec. 31, 2025
DERMAdoctor [Member]  
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   

For the years ended

December 31,

 
   

2025

    

2024

(As Revised)

  
                 

Net sales

   $ —     $ 717  

Cost of goods sold

     —       493  

Gross profit

     —       224  

Operating expenses:

                

Research and development

     —       2  

Sales and marketing

     —       292  

General and administrative

     —       48  

Total operating expenses

     —       342  

Operating loss

     —       (118 )
                 

Loss on divestiture

     —       (871 )
                 

Net loss from discontinued operations

   $ —     $ (989 )
   

For the years ended

December 31,

  
   

2025

    

2024

(As Revised)

  
                 

Operating activities:

                

Net loss from discontinued operations

   $ —     $ (989 )

Adjustments to reconcile net loss to net cash used in operating activities:

                

Non-cash loss on divestiture

     —       865  

Changes in operating assets and liabilities:

                

Accounts receivable

     —       (262 )

Inventory

     —       183  

Prepaid expenses and other current assets

     —       (4 )

Other assets

             15  

Accounts payable and accrued liabilities

     —       63  

Operating lease liabilities

     —       (31 )

Net cash used in operating activities, discontinued operations

     —       (160 )
                 

Investing activities:

                

Proceeds from divestiture

     —       1,070  

Cash transferred to New Age Investments, LLC

     —       (46 )

Net cash provided by investing activities, discontinued operations

     —       1,024  
                 

Net increase in cash and cash equivalents, discontinued operations

   $ —     $ 864